Category: CULTIVATION & RETAIL

Aurora Cannabis Completes Strategic Investment in Micron Waste Technologies

SHARE THIS POST Companies Finalize Collaboration Agreement EDMONTON and VANCOUVER, Jan. 15, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Micron Waste Technologies Inc. (“Micron”) (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), a developer of proprietary digester solutions for the treatment of organic waste, today announced that Aurora has completed a strategic investment in Micron and that the companies have finalized a collaboration agreement pursuant to which both companies will collaborate on the optimization of Micron’s technology for the treatment of organic waste generated in the cultivation and production of cannabis products. Micron has developed a new technology, based on aerobic digestion and subsequent treatment, that converts organic waste into clean water that meets municipal effluent discharge standards. Currently used methods to dispose of organic waste generally require the utilization of municipal landfill sites, which is costly and has a negative impact on the environment. The merits of Micron’s technology have been successfully demonstrated with a grocery supermarket chain located in British Columbia, Canada, with whom Micron has entered into an Memorandum of Understanding to review additional installations. Micron will now install a digester unit at one of Aurora`s facilities, where the companies will jointly work to optimize the digestor for the cannabis industry. Upon successful completion of the project, Aurora intends to acquire multiple units for its various facilities. Micron will retain the...

Read More

AMENDED AND RESTATED NEWS RELEASE – Aurora Cannabis Announces Intention to Launch Takeover Bid for CanniMed Therapeutics Inc.

SHARE THIS POST This amended and restated news release is being issued pursuant to the orders (the “Orders”), dated December 22, 2017, of the Ontario Securities Commission (the “OSC”) and the Financial and Consumer Affairs Authority of Saskatchewan (the “FCAAS” and together with the OSC the “Securities Regulators”). In the section below entitled “Background to the Offer”, Aurora provides further information in response to the following disclosure required by the Orders of the Securities Regulators: The circumstances under which, and the means by which, Aurora became aware that the board of CanniMed Therapeutics Inc.  would be meeting on November 13, 2017 to, among other things, consider for approval an arrangement agreement entered into between CanniMed Therapeutics Inc. and Newstrike Resources Limited. Other information that was: (i) obtained directly or indirectly by Aurora from any person who is, or was at the relevant time, in a special relationship with CanniMed Therapeutics Inc. (by reference to the definitions in subsection 76(5) of the Securities Act (Ontario) and clause 85(1)(a) of the Securities Act (Saskatchewan)); and (ii) material to Aurora in structuring, determining the timing of, delivering or implementing the Aurora Offer. Other information within Aurora’s knowledge that would reasonably be expected to affect the decision of the security holders of CanniMed Therapeutics Inc. to accept or reject the offer made by the Aurora Offer. Aurora’s proposed offer currently valued at $24.00...

Read More

Valens Groworks Receives $602,200 From Warrant Exercise

SHARE THIS POST Vancouver, B.C., January 12, 2018 – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multilicenced, vertically integrated provider of cannabis products, announces it has received $602,200 from the exercise of share purchase warrants. A total of 523,653 warrants were exercised at $1.15 and the Company is issuing a total of 523,653 common shares. The warrants were issued in connection with a non-brokered private placement financing in January 2017 and expired on January 11, 2018. Tyler Robson, CEO of Valens GroWorks commented: “We are very pleased with the level of support received from our shareholders as demonstrated by the closing of our recent $2,000,000 funding, as well as the exercise of these warrants. With our significantly improved treasury, Valens GroWorks is well positioned to advance its corporate initiatives.” About Valens GroWorks Corp. Valens GroWorks is Canadian publicly traded biotechnology company executing on its “plants to premium products” objectives through two wholly-owned subsidiaries located in the heart of British Columbia’s Okanagan Valley. The Company owns 100% of Valens Agritech (“VAL”), commencing cannabis production and sales under a Health Canada Dealer’s License, and a late-stage license applicant to cultivate medical marijuana under the ACMPR for individual patients. Valens also owns 100% of Supra THC Services (“Supra”), a Health Canada licensed cannabis testing lab providing sector-leading analytical and proprietary services to Licensed Producers, ACMPR patients, and the natural...

Read More

Newstrike’s Up Cannabis Enters Into Exclusive Partnership with Canada’s Leading Entertainment Group The Feldman Agency Alliance with Canada’s Top Entertainment Agency Strengthens Foothold for Adult – Use Market

SHARE THIS POST TORONTO, ONTARIO – January 11, 2018 – Newstrike Resources Ltd. (TSX-V:HIP) (“Newstrike” or the “Company”), is pleased to announce that its wholly-owned subsidiary and licensed producer, Up Cannabis Inc. (“Up Cannabis”), has entered into an exclusive partnership with The Feldman Agency, a global leader in talent representation and entertainment consulting. The Feldman Agency will work with Up Cannabis to create strategic partnerships in the music and entertainment space, respecting federal regulations governing the legalized cannabis market. The partnership fortifies Up Cannabis’ position as a premier brand for the adult-use consumer market, opening up myriad opportunities for brand building and awareness, along with an unparalleled brain-trust for maneuvering in the entertainment space. “We are extremely excited to announce this exclusive partnership with Canada’s leading music and entertainment agency,” said Jean Richer, Up Cannabis’ SVP Sales and Marketing. “The Feldman Agency is a global player which will provide the Up brand with unprecedented access to our core adult demographics, representing millions of consumers. Music is a fundamental element of everything we do. In fact, it’s at the foundation of our Unique Growing Proposition. We know this alliance will help us connect meaningfully with Canadians everywhere,” Richer added. The Feldman Agency has a roster of more than 250 recording artists, built on 47 years of industry-leading accomplishments. The agency currently represents a wide variety of musical talent across a...

Read More

Maricann Group Inc. Announces Closing of $40 Million Private Placement

SHARE THIS POST TORONTO, ONTARIO–(Marketwired – Jan. 9, 2018) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) (“Maricann” or the “Company”) is pleased to announce the closing of its previously announced private placement offering (the “Offering”) of special warrants (the “Special Warrants”) for aggregate gross proceeds of $40,250,000. Eight Capital, as sole bookrunner and co-lead agent with Canaccord Genuity Corp., and together with Industrial Alliance Securities Inc. (the “Agents”), acted as the agents in connection with the Offering. The aggregate gross proceeds of the Offering includes the full exercise of the over-allotment option granted to the Agents in connection with the Offering. Pursuant to the Offering, the Company issued 20,125,000 Special Warrants, at a price of $2.00 per Special Warrant. Each Special Warrant is automatically exercisable, for no additional consideration, into units of the Company (the “Units”) on the earlier of: (i) the date that is three business days following the date on which the Company obtains receipt from the applicable securities regulatory authorities (the “Securities Commissions”) for a (final) prospectus (the “Qualifying Prospectus”) qualifying distribution of the Units issuable upon exercise of the Special Warrants; and (ii) May 10, 2018. Upon automatic exercise of the Special Warrants, each Unit shall consist of one common share of the Company (each, a “Common Share”) and one-half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”)....

Read More

Canopy Rivers Closes Oversubscribed $26 Million Financing Via Private Placement

SHARE THIS POST January 10, 2018 Smiths Falls & Toronto, ON– Canopy Growth Corporation (“Canopy Growth”) (TSX:WEED) is pleased to announce that its partly owned subsidiary, Canopy Rivers Corporation (“Canopy Rivers”) has closed a non-brokered private placement offering of 23,636,363 Class B common shares (the “Shares”) at a price of $1.10 per Share. Pursuant to the offering, Canopy Rivers raised aggregate gross proceeds of approximately $26 million. Canopy Growth subscribed for 4,673,938 Shares for $5,141,331.80. “Canopy Rivers has efficiently allocated the initial capital and quickly established an attractive portfolio of diversified investments including licensed producers, late stage applicants, ancillary product developers, and industry leading brands,” says Bruce Linton, CEO of Canopy Growth & Chairman of Canopy Rivers. Founded in April 2017, Canopy Rivers was formed to complete streaming deals to flow product through Canopy Growth’s platform and diversify supply channels to satisfy the needs of Canada’s largest group of cannabis customers. As the Canopy Rivers leadership team evaluated the landscape and identified additional deal potential, a more robust business model matured to complement streaming activities. Today, Canopy Rivers has a portfolio of diversified investments and represents a balanced mix of equity, debt, royalty and profit sharing investment structures.   “Our team has curated a tier one group of complimentary but unique investee companies in a short period of time,” said Sean McNulty, Co-founder of Canopy Rivers. “We have pioneered a...

Read More